4 promising biotechs for 2018

Financial journalist and commentator on 3AW and Sky Business
Print This Post A A A

Biotech is definitely an area where Australia operates at a world-class level with the expertise of its medical researchers.

Australia has generated some major biotech success stories. Prime among these are Gardasil, the vaccine against the human papillomavirus (HPV) and thus, cervical cancer, which came out of the work of Jian Zhou and Ian Frazer at the University of Queensland, and was commercialised by CSL; and the influenza treatment, Zanamivir, developed at the CSIRO, in collaboration with the Victorian College of Pharmacy and Monash University.

CSL – the former Commonwealth Serum Laboratories – has become a global biotech leader, the world’s largest maker of plasma-based therapies, and a major player in vaccines.

Take a free trial to continue reading

Already have an account? Login to continue reading.

By proceeding you understand and agree to the site's terms and conditions

Also from this edition